{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:47:52Z","timestamp":1785300472559,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2503300"],"award-info":[{"award-number":["2022YFC2503300"]}]},{"name":"NSFC Projects for International Cooperation and Exchanges","award":["82220108015"],"award-info":[{"award-number":["82220108015"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2023MH213"],"award-info":[{"award-number":["ZR2023MH213"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao Science and Technology Benefiting the People Demonstration Special Program","award":["25-1-5-smjk-20-nsh"],"award-info":[{"award-number":["25-1-5-smjk-20-nsh"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82301003"],"award-info":[{"award-number":["82301003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03768-z","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:05:30Z","timestamp":1771466730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study"],"prefix":"10.1186","volume":"28","author":[{"given":"Kai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-5323","authenticated-orcid":false,"given":"Mingshu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-3952","authenticated-orcid":false,"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"10287","key":"3768_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, et al. Gout Lancet. 2021;397(10287):1843\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9.","journal-title":"Gout Lancet"},{"issue":"Suppl 2","key":"3768_CR2","doi-asserted-by":"publisher","first-page":"i9","DOI":"10.1093\/rheumatology\/kep087","volume":"48","author":"F Perez-Ruiz","year":"2009","unstructured":"Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology (Oxford). 2009;48(Suppl 2):i9\u201314. https:\/\/doi.org\/10.1093\/rheumatology\/kep087.","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"3768_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s40265-023-01944-y","volume":"83","author":"R Terkeltaub","year":"2023","unstructured":"Terkeltaub R. Emerging Urate-Lowering drugs and Pharmacologic treatment strategies for gout: A narrative review. Drugs. 2023;83(16):1501\u201321. https:\/\/doi.org\/10.1007\/s40265-023-01944-y.","journal-title":"Drugs"},{"issue":"10","key":"3768_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-022-00816-1","volume":"18","author":"LK Stamp","year":"2022","unstructured":"Stamp LK, Dalbeth N. Critical appraisal of serum urate targets in the management of gout. Nat Rev Rheumatol. 2022;18(10):603\u20139. https:\/\/doi.org\/10.1038\/s41584-022-00816-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3768_CR5","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/S2665-9913(21)00319-2","volume":"4","author":"LK Stamp","year":"2022","unstructured":"Stamp LK, Frampton C, Morillon MB, et al. Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials. Lancet Rheumatol. 2022;4(1):e53\u201360. https:\/\/doi.org\/10.1016\/S2665-9913(21)00319-2.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"3768_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamainternmed.2024.6212","volume":"185","author":"Y Wang","year":"2025","unstructured":"Wang Y, Dalbeth N, Terkeltaub R, et al. Target serum urate achievement and chronic kidney disease progression in patients with gout and kidney disease. JAMA Intern Med. 2025;185(1):74\u201382. https:\/\/doi.org\/10.1001\/jamainternmed.2024.6212.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"3768_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-023-03228-y","volume":"25","author":"H Qi","year":"2023","unstructured":"Qi H, Sun M, Terkeltaub R, et al. Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout. Arthritis Res Ther. 2023;25(1):241. https:\/\/doi.org\/10.1186\/s13075-023-03228-y.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3768_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.25283","volume":"76","author":"X Xue","year":"2024","unstructured":"Xue X, Sun M, Yan F, et al. Superiority of Low-Dose benzbromarone Add-On to Low-Dose febuxostat compared with febuxostat monotherapy in gout with Combined-Type hyperuricemia. Arthritis Care Res (Hoboken). 2024;76(5):703\u201311. https:\/\/doi.org\/10.1002\/acr.25283.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"3768_CR9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/art.42838","volume":"76","author":"H Qi","year":"2024","unstructured":"Qi H, Sun M, Terkeltaub R, et al. Hyperuricemia subtypes classified according to renal uric acid handling manifesting distinct phenotypic and genetic profiles in people with gout. Arthritis Rheumatol. 2024;76(7):1130\u201340. https:\/\/doi.org\/10.1002\/art.42838.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"3768_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/annrheumdis-2019-216644","volume":"79","author":"A Nakayama","year":"2020","unstructured":"Nakayama A, Nakatochi M, Kawamura Y, et al. Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients. Ann Rheum Dis. 2020;79(5):657\u201365. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216644.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3768_CR11","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.42266","volume":"74","author":"F Yan","year":"2022","unstructured":"Yan F, Xue X, Lu J, et al. Superiority of Low-Dose benzbromarone to Low-Dose febuxostat in a Prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion. Arthritis Rheumatol. 2022;74(12):2015\u201323. https:\/\/doi.org\/10.1002\/art.42266.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3768_CR12","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/rheumatology\/keae262","volume":"63","author":"EH Kang","year":"2024","unstructured":"Kang EH, Shin A, Park CS, et al. Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study. Rheumatology (Oxford). 2024;63(9):2433\u201341. https:\/\/doi.org\/10.1093\/rheumatology\/keae262.","journal-title":"Rheumatology (Oxford)"},{"issue":"15","key":"3768_CR13","doi-asserted-by":"publisher","first-page":"e15214","DOI":"10.1097\/MD.0000000000015214","volume":"98","author":"X Ye","year":"2019","unstructured":"Ye X, Wu J, Tang K, et al. Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: two case reports. Med (Baltim). 2019;98(15):e15214. https:\/\/doi.org\/10.1097\/MD.0000000000015214.","journal-title":"Med (Baltim)"},{"issue":"5","key":"3768_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/s0168-8278(00)80263-9","volume":"32","author":"H Wagayama","year":"2000","unstructured":"Wagayama H, Shiraki K, Sugimoto K, et al. Fatal fulminant hepatic failure associated with benzbromarone. J Hepatol. 2000;32(5):874. https:\/\/doi.org\/10.1016\/s0168-8278(00)80263-9.","journal-title":"J Hepatol"},{"issue":"1","key":"3768_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-023-03152-1","volume":"25","author":"C Wang","year":"2023","unstructured":"Wang C, Sun W, Dalbeth N, et al. Efficacy and safety of tart Cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study. Arthritis Res Ther. 2023;25(1):164. https:\/\/doi.org\/10.1186\/s13075-023-03152-1.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3768_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-022-02725-w","volume":"24","author":"Y He","year":"2022","unstructured":"He Y, Xue X, Terkeltaub R, et al. Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional study. Arthritis Res Ther. 2022;24(1):32. https:\/\/doi.org\/10.1186\/s13075-022-02725-w.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3768_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00240-017-0962-5","volume":"45","author":"A Trinchieri","year":"2017","unstructured":"Trinchieri A, Montanari E. Prevalence of renal uric acid stones in the adult. Urolithiasis. 2017;45(6):553\u2013. https:\/\/doi.org\/10.1007\/s00240-017-0962-5. \u200962.","journal-title":"Urolithiasis"},{"key":"3768_CR18","doi-asserted-by":"publisher","unstructured":"Shimodaira M, Okaniwa S, Nakayama T. Association of low urine pH with insulin resistance in Non-Diabetic Japanese Subjects. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association. 2018;10\u20131055. https:\/\/doi.org\/10.1055\/s-0043-122943.","DOI":"10.1055\/s-0043-122943"},{"issue":"7","key":"3768_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/kex250","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, et al. The British society for rheumatology guideline for the management of gout. Rheumatology (Oxford). 2017;56(7):1056\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kex250.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3768_CR20","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American college of rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken). 2020;72(6):744\u201360. https:\/\/doi.org\/10.1002\/acr.24180.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"3768_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/1756-185X.13266","volume":"21","author":"KH Yu","year":"2018","unstructured":"Yu KH, Chen DY, Chen JH, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772\u201387. https:\/\/doi.org\/10.1111\/1756-185X.13266.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"3768_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3768_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/07435800.2010.497178","volume":"35","author":"J Saito","year":"2010","unstructured":"Saito J, Matsuzawa Y, Ito H, et al. The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the Xanthine oxidase inhibitor allopurinol. Endocr Res. 2010;35(4):145\u201354. https:\/\/doi.org\/10.3109\/07435800.2010.497178.","journal-title":"Endocr Res"},{"issue":"6","key":"3768_CR24","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1093\/rheumatology\/keaf091","volume":"64","author":"C Wang","year":"2025","unstructured":"Wang C, Guo K, Dalbeth N, et al. Impact of adding urine alkalization therapy to Xanthine oxidase inhibitor in gout management: a prospective cohort study. Rheumatology (Oxford). 2025;64(6):3509\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/keaf091.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3768_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, et al. 2015 gout classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789\u201398. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237.","journal-title":"Ann Rheum Dis"},{"key":"3768_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764. https:\/\/doi.org\/10.1038\/ncomms1756.","journal-title":"Nat Commun"},{"issue":"9","key":"3768_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"3768_CR28","doi-asserted-by":"publisher","first-page":"103707","DOI":"10.1016\/j.ebiom.2021.103707","volume":"74","author":"Q Wu","year":"2021","unstructured":"Wu Q, Li J, Sun X, et al. Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants. EBioMedicine. 2021;74:103707. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103707.","journal-title":"EBioMedicine"},{"issue":"1","key":"3768_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette P, Clerson P, Perissin L, et al. Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis. 2015;74(1):142\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203779.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3768_CR30","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/ard.2006.063768","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis. 2007;66(10):1374\u20137. https:\/\/doi.org\/10.1136\/ard.2006.063768.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3768_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/1573405617666210707164124","volume":"18","author":"Z Huang","year":"2022","unstructured":"Huang Z, Li Z, Xiao J, et al. Dual-energy computed tomography for the diagnosis of acute gouty arthritis. Curr Med Imaging. 2022;18(3):305\u201311. https:\/\/doi.org\/10.2174\/1573405617666210707164124.","journal-title":"Curr Med Imaging"},{"issue":"5","key":"3768_CR32","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/art.33483","volume":"64","author":"AL Gaffo","year":"2012","unstructured":"Gaffo AL, Schumacher HR, Saag KG, et al. Developing a provisional definition of flare in patients with established gout. Arthritis Rheum. 2012;64(5):1508\u201317. https:\/\/doi.org\/10.1002\/art.33483.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3768_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","volume":"30","author":"H Yamanaka","year":"2011","unstructured":"Yamanaka H. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1018\u201329. https:\/\/doi.org\/10.1080\/15257770.2011.596496.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3768_CR34","doi-asserted-by":"publisher","unstructured":"Butler F, Alghubayshi A, Roman Y. The epidemiology and genetics of hyperuricemia and gout across major Racial groups: A literature review and population genetics secondary database analysis. J Pers Med. 2021;11(3). https:\/\/doi.org\/10.3390\/jpm11030231.","DOI":"10.3390\/jpm11030231"},{"key":"3768_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fphar.2016.00518","volume":"7","author":"H Miyata","year":"2016","unstructured":"Miyata H, Takada T, Toyoda Y, et al. Identification of febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations. Front Pharmacol. 2016;7:518. https:\/\/doi.org\/10.3389\/fphar.2016.00518.","journal-title":"Front Pharmacol"},{"key":"3768_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/art.43118","author":"R Terkeltaub","year":"2025","unstructured":"Terkeltaub R, Dodd D. The gut Microbiome in hyperuricemia and gout. Arthritis Rheumatol. 2025. https:\/\/doi.org\/10.1002\/art.43118.","journal-title":"Arthritis Rheumatol"},{"issue":"24","key":"3768_CR37","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1158\/1078-0432.CCR-17-0983","volume":"23","author":"J Li","year":"2017","unstructured":"Li J, Wu J, Bao X, et al. Quantitative and mechanistic Understanding of AZD1775 penetration across human Blood-Brain barrier in glioblastoma patients using an IVIVE-PBPK modeling Approach[J]. Clin Cancer Res. 2017;23(24):7454\u201366. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0983.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3768_CR38","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1039\/c9fo00509a","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Li M, Wu JL, et al. Effect of lemon water soluble extract on hyperuricemia in a mouse model. Food Funct. 2019;10(9):6000\u20138. https:\/\/doi.org\/10.1039\/c9fo00509a.","journal-title":"Food Funct"},{"key":"3768_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2891-9-45","volume":"9","author":"A Kanbara","year":"2010","unstructured":"Kanbara A, Hakoda M, Seyama I. Urine alkalization facilitates uric acid excretion. Nutr J. 2010;9:45. https:\/\/doi.org\/10.1186\/1475-2891-9-45.","journal-title":"Nutr J"},{"issue":"2","key":"3768_CR40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/toxsci\/kfq219","volume":"117","author":"CH Yang","year":"2010","unstructured":"Yang CH, Glover KP, Han X. Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates. Toxicol Sci. 2010;117(2):294\u2013302. https:\/\/doi.org\/10.1093\/toxsci\/kfq219.","journal-title":"Toxicol Sci"},{"issue":"11","key":"3768_CR41","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/nu11112562","volume":"11","author":"S Oshima","year":"2019","unstructured":"Oshima S, Shiiya S, Nakamura Y. Combined supplementation with Glycine and Tryptophan reduces Purine-Induced serum uric acid elevation by accelerating urinary uric acid excretion: A Randomized, Single-Blind, Placebo-Controlled, crossover study. Nutrients. 2019;11(11):2562. https:\/\/doi.org\/10.3390\/nu11112562.","journal-title":"Nutrients"},{"key":"3768_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1475-2891-11-39","volume":"11","author":"A Kanbara","year":"2012","unstructured":"Kanbara A, Miura Y, Hyogo H, et al. Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid. Nutr J. 2012;11:39. https:\/\/doi.org\/10.1186\/1475-2891-11-39.","journal-title":"Nutr J"},{"key":"3768_CR43","doi-asserted-by":"publisher","first-page":"773220","DOI":"10.3389\/fnut.2022.773220","volume":"9","author":"X Feng","year":"2022","unstructured":"Feng X, Yang Y, Xie H, et al. The association between hyperuricemia and obesity metabolic phenotypes in Chinese general population: A retrospective analysis. Front Nutr. 2022;9:773220. https:\/\/doi.org\/10.3389\/fnut.2022.773220.","journal-title":"Front Nutr"},{"key":"3768_CR44","doi-asserted-by":"publisher","first-page":"821689","DOI":"10.3389\/fendo.2022.821689","volume":"13","author":"C Yang","year":"2022","unstructured":"Yang C, He Q, Chen Z, et al. A bidirectional relationship between hyperuricemia and metabolic Dysfunction-Associated fatty liver disease. Front Endocrinol. 2022;13:821689. https:\/\/doi.org\/10.3389\/fendo.2022.821689.","journal-title":"Front Endocrinol"},{"issue":"5","key":"3768_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/metabo15050318","volume":"15","author":"J Huang","year":"2025","unstructured":"Huang J, Li R, Sia H, et al. Fatty liver and hyperuricemia in workers: combined effects on metabolic dysfunction and the role of lifestyle factors. Metabolites. 2025;15(5):318. https:\/\/doi.org\/10.3390\/metabo15050318.","journal-title":"Metabolites"},{"issue":"11","key":"3768_CR46","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/art.41779","volume":"73","author":"N McCormick","year":"2021","unstructured":"McCormick N, O\u2019Connor MJ, Yokose C, et al. Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional Mendelian randomization. Arthritis Rheumatol. 2021;73(11):2096\u2013104. https:\/\/doi.org\/10.1002\/art.41779.","journal-title":"Arthritis Rheumatol"},{"key":"3768_CR47","doi-asserted-by":"publisher","first-page":"713710","DOI":"10.3389\/fphys.2021.713710","volume":"12","author":"AK Mandal","year":"2021","unstructured":"Mandal AK, Leask MP, Sumpter NA, et al. Genetic and physiological effects of insulin on human urate homeostasis. Front Physiol. 2021;12:713710. https:\/\/doi.org\/10.3389\/fphys.2021.713710.","journal-title":"Front Physiol"},{"issue":"2","key":"3768_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/BOR.0000000000000779","volume":"33","author":"C Yokose","year":"2021","unstructured":"Yokose C, McCormick N, Choi HK. The role of diet in hyperuricemia and gout. Curr Opin Rheumatol. 2021;33(2):135\u201344. https:\/\/doi.org\/10.1097\/BOR.0000000000000779.","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"3768_CR49","doi-asserted-by":"publisher","first-page":"e14404","DOI":"10.1111\/jfbc.14404","volume":"46","author":"N Yadikar","year":"2022","unstructured":"Yadikar N, Ahmet A, Zhu J, et al. Exploring the mechanism of citric acid for treating glucose metabolism disorder induced by hyperlipidemia. J Food Biochem. 2022;46(12):e14404. https:\/\/doi.org\/10.1111\/jfbc.14404.","journal-title":"J Food Biochem"},{"issue":"2","key":"3768_CR50","doi-asserted-by":"publisher","first-page":"168102","DOI":"10.1016\/j.bbadis.2025.168102","volume":"1872","author":"X Xia","year":"2026","unstructured":"Xia X, Niu H, Xu C, et al. Revisiting the metabolic crosstalk between type 2 diabetes and hyperuricemia: pathophysiological insights and therapeutic perspectives. Biochimica et biophysica acta. Mol Basis Disease. 2026;1872(2):168102. https:\/\/doi.org\/10.1016\/j.bbadis.2025.168102.","journal-title":"Mol Basis Disease"},{"issue":"12","key":"3768_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","volume":"18","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127. https:\/\/doi.org\/10.1007\/s11892-018-1101-6.","journal-title":"Curr Diab Rep"},{"issue":"9","key":"3768_CR52","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","volume":"32","author":"JD Sparks","year":"2012","unstructured":"Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32(9):2104\u201312. https:\/\/doi.org\/10.1161\/ATVBAHA.111.241463.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3768_CR53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","volume":"64","author":"X Wan","year":"2016","unstructured":"Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.022.","journal-title":"J Hepatol"},{"key":"3768_CR54","doi-asserted-by":"publisher","unstructured":"Yanai H, Adachi H, Hakoshima M, et al. Molecular biological and clinical Understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic Syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17). https:\/\/doi.org\/10.3390\/ijms22179221.","DOI":"10.3390\/ijms22179221"},{"issue":"1","key":"3768_CR55","doi-asserted-by":"publisher","first-page":"2434186","DOI":"10.1080\/07853890.2024.2434186","volume":"56","author":"H He","year":"2024","unstructured":"He H, Cheng Q, Chen S, et al. Triglyceride-glucose index and its additive interaction with ABCG2\/SLC2A9 polygenic risk score on hyperuricemia in middle age and older adults: findings from the DLCC and BHMC study. Ann Med. 2024;56(1):2434186. https:\/\/doi.org\/10.1080\/07853890.2024.2434186.","journal-title":"Ann Med"},{"issue":"3","key":"3768_CR56","doi-asserted-by":"publisher","first-page":"F826","DOI":"10.1152\/ajprenal.00012.2017","volume":"313","author":"D Toyoki","year":"2017","unstructured":"Toyoki D, Shibata S, Kuribayashi-Okuma E, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol Ren Physiol. 2017;313(3):F826\u201334. https:\/\/doi.org\/10.1152\/ajprenal.00012.2017.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"7","key":"3768_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499\u2013516. https:\/\/doi.org\/10.7326\/0003-4819-143-7-200510040-00009.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3768_CR58","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","volume":"9","author":"E Muscelli","year":"1996","unstructured":"Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9(8):746\u201352. https:\/\/doi.org\/10.1016\/0895-7061(96)00098-2.","journal-title":"Am J Hypertens"},{"issue":"1","key":"3768_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/cs0920051","volume":"92","author":"JC Ter Maaten","year":"1997","unstructured":"Ter Maaten JC, Voorburg A, Heine RJ, et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond). 1997;92(1):51\u20138. https:\/\/doi.org\/10.1042\/cs0920051.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"3768_CR60","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.42940","volume":"76","author":"AK Mandal","year":"2024","unstructured":"Mandal AK, Merriman TR, Choi HK, et al. Caffeine inhibits both basal and Insulin-Activated urate transport. Arthritis Rheumatol. 2024;76(11):1658\u201369. https:\/\/doi.org\/10.1002\/art.42940.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3768_CR61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0021-9150(00)00745-0","volume":"155","author":"SJ Bakker","year":"2001","unstructured":"Bakker SJ, Gans RO, ter Maaten JC, et al. The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis. 2001;155(2):283\u201390. https:\/\/doi.org\/10.1016\/s0021-9150(00)00745-0.","journal-title":"Atherosclerosis"},{"issue":"2","key":"3768_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11926-012-0307-x","volume":"15","author":"JA Singh","year":"2013","unstructured":"Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013;15(2):307. https:\/\/doi.org\/10.1007\/s11926-012-0307-x.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03768-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:12:56Z","timestamp":1774519976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3768"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03768-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7578472\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the Affiliated Hospital of Qingdao University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}